Loading insider details...
Beta
Latest Form 4 (Jun 25, 2026): Grant/Award of 28,000 FHTX shares, $114.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 25, 2026 | Foghorn Therapeutics Inc. (FHTX) | Grant/Award | 28,000 | $114.2K |
| May 2, 2025 | Foghorn Therapeutics Inc. (FHTX) | Grant/Award | 50,000 | $208.0K |
| Feb 12, 2025 | Syndax Pharmaceuticals Inc (SNDX) | Sale | 4,618 | $71.6K |
| Feb 7, 2025 | Syndax Pharmaceuticals Inc (SNDX) | Grant/Award | 18,500 | n/a |
| Dec 12, 2024 | Zymeworks Inc. (ZYME) | Grant/Award | 31,000 | n/a |
| Apr 3, 2024 | Zymeworks Inc. (ZYME) | Grant/Award | 74,000 | n/a |
| Feb 9, 2024 | Syndax Pharmaceuticals Inc (SNDX) | Grant/Award | 34,688 | n/a |
| Apr 12, 2023 | Syndax Pharmaceuticals Inc (SNDX) | Grant/Award | 250,000 | $4.84M |